

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axonemal dynein complex assembly (GO:0070286) | 7.61713708 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.67574958 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.67574958 |
| 4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.53838641 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.36013489 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 6.36013489 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.01606636 |
| 8 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.91720506 |
| 9 | sulfur amino acid catabolic process (GO:0000098) | 5.86692515 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 5.85407478 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.44583897 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.39490245 |
| 13 | short-chain fatty acid metabolic process (GO:0046459) | 5.38570301 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 5.38432298 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 5.38432298 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.38432298 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.29160229 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.02350600 |
| 19 | tryptophan metabolic process (GO:0006568) | 4.97118327 |
| 20 | cysteine metabolic process (GO:0006534) | 4.95872490 |
| 21 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.90970819 |
| 22 | urea metabolic process (GO:0019627) | 4.81708950 |
| 23 | urea cycle (GO:0000050) | 4.81708950 |
| 24 | cilium movement (GO:0003341) | 4.80965338 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.71310021 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69346069 |
| 27 | reverse cholesterol transport (GO:0043691) | 4.63115888 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 4.59428941 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 4.58990916 |
| 30 | motile cilium assembly (GO:0044458) | 4.57118580 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.56745180 |
| 32 | bile acid metabolic process (GO:0008206) | 4.51352059 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 4.47304366 |
| 34 | amino-acid betaine metabolic process (GO:0006577) | 4.44097950 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.43340283 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.43340283 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.43340283 |
| 38 | regulation of fibrinolysis (GO:0051917) | 4.40947728 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.40091323 |
| 40 | complement activation, alternative pathway (GO:0006957) | 4.39024663 |
| 41 | protein carboxylation (GO:0018214) | 4.37621094 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.37621094 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.34926365 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.34010515 |
| 45 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.31726875 |
| 46 | regulation of complement activation (GO:0030449) | 4.28199529 |
| 47 | negative regulation of sterol transport (GO:0032372) | 4.26390378 |
| 48 | negative regulation of cholesterol transport (GO:0032375) | 4.26390378 |
| 49 | glutamate metabolic process (GO:0006536) | 4.25974500 |
| 50 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.25090772 |
| 51 | lysine catabolic process (GO:0006554) | 4.24188731 |
| 52 | lysine metabolic process (GO:0006553) | 4.24188731 |
| 53 | homocysteine metabolic process (GO:0050667) | 4.22154873 |
| 54 | cellular amino acid catabolic process (GO:0009063) | 4.21261872 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.19248906 |
| 56 | glycine metabolic process (GO:0006544) | 4.17285461 |
| 57 | coenzyme catabolic process (GO:0009109) | 4.12630129 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 4.08099781 |
| 59 | phospholipid efflux (GO:0033700) | 4.06296775 |
| 60 | serine family amino acid biosynthetic process (GO:0009070) | 4.03073616 |
| 61 | low-density lipoprotein particle remodeling (GO:0034374) | 4.00665918 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.95230039 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.95230039 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.95169139 |
| 65 | serine family amino acid metabolic process (GO:0009069) | 3.94365357 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 3.93755024 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 3.92062499 |
| 68 | primary alcohol catabolic process (GO:0034310) | 3.89036254 |
| 69 | non-recombinational repair (GO:0000726) | 3.86300588 |
| 70 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.86300588 |
| 71 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.84623667 |
| 72 | fatty acid beta-oxidation (GO:0006635) | 3.84034533 |
| 73 | bile acid and bile salt transport (GO:0015721) | 3.83034091 |
| 74 | DNA double-strand break processing (GO:0000729) | 3.81767922 |
| 75 | carboxylic acid catabolic process (GO:0046395) | 3.80435414 |
| 76 | organic acid catabolic process (GO:0016054) | 3.80435414 |
| 77 | epithelial cilium movement (GO:0003351) | 3.78961911 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.77586644 |
| 79 | regulation of thymocyte apoptotic process (GO:0070243) | 3.77511385 |
| 80 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.74312344 |
| 81 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.73494406 |
| 82 | ethanol oxidation (GO:0006069) | 3.72022559 |
| 83 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 3.71883115 |
| 84 | fatty acid oxidation (GO:0019395) | 3.71151542 |
| 85 | cellular glucuronidation (GO:0052695) | 3.70888475 |
| 86 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.68429387 |
| 87 | lipid oxidation (GO:0034440) | 3.67745205 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67478705 |
| 89 | cholesterol efflux (GO:0033344) | 3.66485595 |
| 90 | monocarboxylic acid catabolic process (GO:0072329) | 3.63704035 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 3.62707854 |
| 92 | cellular biogenic amine catabolic process (GO:0042402) | 3.62331470 |
| 93 | amine catabolic process (GO:0009310) | 3.62331470 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.61476884 |
| 95 | indolalkylamine metabolic process (GO:0006586) | 3.61125163 |
| 96 | fatty acid catabolic process (GO:0009062) | 3.59915306 |
| 97 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.57069867 |
| 98 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.57069867 |
| 99 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.57069867 |
| 100 | ketone body metabolic process (GO:1902224) | 3.56698777 |
| 101 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.55808640 |
| 102 | arginine metabolic process (GO:0006525) | 3.54519714 |
| 103 | T-helper 1 type immune response (GO:0042088) | 3.54306828 |
| 104 | L-serine metabolic process (GO:0006563) | 3.52915535 |
| 105 | imidazole-containing compound metabolic process (GO:0052803) | 3.51672640 |
| 106 | carnitine metabolic process (GO:0009437) | 3.49031000 |
| 107 | retinal cone cell development (GO:0046549) | 3.47823191 |
| 108 | regulation of cholesterol metabolic process (GO:0090181) | 3.47813949 |
| 109 | dicarboxylic acid catabolic process (GO:0043649) | 3.47712729 |
| 110 | copper ion transport (GO:0006825) | 3.44527602 |
| 111 | fructose metabolic process (GO:0006000) | 3.44157657 |
| 112 | acetyl-CoA metabolic process (GO:0006084) | 3.41737144 |
| 113 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.40660804 |
| 114 | aspartate family amino acid catabolic process (GO:0009068) | 3.40543646 |
| 115 | response to xenobiotic stimulus (GO:0009410) | 3.37667783 |
| 116 | cofactor catabolic process (GO:0051187) | 3.36450580 |
| 117 | drug catabolic process (GO:0042737) | 3.36406579 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.36394750 |
| 119 | very long-chain fatty acid metabolic process (GO:0000038) | 3.35595550 |
| 120 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35375028 |
| 121 | cholesterol homeostasis (GO:0042632) | 3.34706962 |
| 122 | plasma lipoprotein particle organization (GO:0071827) | 3.33653569 |
| 123 | ethanol metabolic process (GO:0006067) | 3.31229304 |
| 124 | transcription from mitochondrial promoter (GO:0006390) | 3.19847159 |
| 125 | diterpenoid biosynthetic process (GO:0016102) | 3.18571722 |
| 126 | mitochondrial DNA replication (GO:0006264) | 3.15922559 |
| 127 | immunoglobulin mediated immune response (GO:0016064) | 3.08744726 |
| 128 | axoneme assembly (GO:0035082) | 2.96786192 |
| 129 | NAD biosynthetic process (GO:0009435) | 2.95387578 |
| 130 | positive regulation of osteoclast differentiation (GO:0045672) | 2.91121735 |
| 131 | regulation of immunoglobulin secretion (GO:0051023) | 2.90493822 |
| 132 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.86539918 |
| 133 | neutrophil activation involved in immune response (GO:0002283) | 2.82378693 |
| 134 | copper ion homeostasis (GO:0055070) | 2.80988371 |
| 135 | cytochrome complex assembly (GO:0017004) | 2.78920041 |
| 136 | B cell mediated immunity (GO:0019724) | 2.78835089 |
| 137 | terpenoid biosynthetic process (GO:0016114) | 2.77970229 |
| 138 | myeloid dendritic cell differentiation (GO:0043011) | 2.77938164 |
| 139 | positive regulation of T cell cytokine production (GO:0002726) | 2.75455628 |
| 140 | diol metabolic process (GO:0034311) | 2.73326708 |
| 141 | cellular response to ethanol (GO:0071361) | 2.72155610 |
| 142 | oxidative phosphorylation (GO:0006119) | 2.71510786 |
| 143 | tolerance induction (GO:0002507) | 2.71481766 |
| 144 | left/right axis specification (GO:0070986) | 2.65179065 |
| 145 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.65117727 |
| 146 | cytokine biosynthetic process (GO:0042089) | 2.64206079 |
| 147 | Golgi transport vesicle coating (GO:0048200) | 2.63931960 |
| 148 | COPI coating of Golgi vesicle (GO:0048205) | 2.63931960 |
| 149 | cellular copper ion homeostasis (GO:0006878) | 2.62295762 |
| 150 | negative regulation of T cell differentiation (GO:0045581) | 2.61368912 |
| 151 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.59619591 |
| 152 | positive regulation of chromosome segregation (GO:0051984) | 2.57343840 |
| 153 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.54827272 |
| 154 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.54827272 |
| 155 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.52689986 |
| 156 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.49784886 |
| 157 | vitamin transmembrane transport (GO:0035461) | 2.49151475 |
| 158 | sphingoid metabolic process (GO:0046519) | 2.48097329 |
| 159 | sphingosine metabolic process (GO:0006670) | 2.46863295 |
| 160 | left/right pattern formation (GO:0060972) | 2.45885705 |
| 161 | myeloid dendritic cell activation (GO:0001773) | 2.45223452 |
| 162 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.44426148 |
| 163 | type I interferon signaling pathway (GO:0060337) | 2.44156915 |
| 164 | cellular response to type I interferon (GO:0071357) | 2.44156915 |
| 165 | response to type I interferon (GO:0034340) | 2.42378563 |
| 166 | negative regulation of interleukin-12 production (GO:0032695) | 2.39450832 |
| 167 | regulation of T cell apoptotic process (GO:0070232) | 2.38801963 |
| 168 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.37284304 |
| 169 | histone H2B ubiquitination (GO:0033523) | 2.35836273 |
| 170 | regulation of germinal center formation (GO:0002634) | 2.35541429 |
| 171 | regulation of interferon-alpha production (GO:0032647) | 2.33064604 |
| 172 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.31849863 |
| 173 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.31616791 |
| 174 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.31491166 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.31491166 |
| 176 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.31026357 |
| 177 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.28461728 |
| 178 | actin nucleation (GO:0045010) | 2.28134307 |
| 179 | ceramide catabolic process (GO:0046514) | 2.27600991 |
| 180 | pyridine-containing compound biosynthetic process (GO:0072525) | 2.27142709 |
| 181 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.26631078 |
| 182 | response to hydroperoxide (GO:0033194) | 2.25072278 |
| 183 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.25025158 |
| 184 | isotype switching (GO:0045190) | 2.25025158 |
| 185 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.25025158 |
| 186 | eosinophil chemotaxis (GO:0048245) | 2.23608939 |
| 187 | regulation of tolerance induction (GO:0002643) | 2.22467942 |
| 188 | positive regulation of tolerance induction (GO:0002645) | 2.20063426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.88286803 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.00060988 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.34743317 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.88276561 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.07959260 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.02712755 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.47789825 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.50741709 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.41043409 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.33799600 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95167825 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89649680 |
| 13 | * ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.85878750 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.64039240 |
| 15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39765122 |
| 16 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.11645151 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.10874744 |
| 18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.05383553 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6375195 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.94645957 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94412853 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.94171256 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88066726 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.87684980 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86584244 |
| 26 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.83525597 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79705506 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.78808773 |
| 29 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.76955036 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76157806 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.68454201 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.66954836 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64415676 |
| 34 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.64189873 |
| 35 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.62619418 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.59170511 |
| 37 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.58292205 |
| 38 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.54679234 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.54290459 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50754683 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.50747628 |
| 42 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47495849 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46966429 |
| 44 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46837678 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46787718 |
| 46 | MYB_26560356_Chip-Seq_TH1_Human | 1.42316931 |
| 47 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.39082356 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.39082268 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.37200929 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36490236 |
| 51 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.34176398 |
| 52 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33031774 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32853552 |
| 54 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32782814 |
| 55 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.29449368 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.29035609 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.25492327 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24718660 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22327532 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22143850 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21448401 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.19758909 |
| 63 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19066771 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18092696 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17160605 |
| 66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.16085854 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.15877849 |
| 68 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.15263253 |
| 69 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.14878219 |
| 70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14100468 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14000142 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12883574 |
| 73 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12637899 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11528604 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10816016 |
| 76 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10789064 |
| 77 | MAF_26560356_Chip-Seq_TH1_Human | 1.08249253 |
| 78 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05991536 |
| 79 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04773908 |
| 80 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.04539470 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02054713 |
| 82 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02015143 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01914318 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00213238 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00078560 |
| 86 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.99239456 |
| 87 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98203616 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.97893285 |
| 89 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.97806319 |
| 90 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97288159 |
| 91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.96626968 |
| 92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96335928 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95569550 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94979501 |
| 95 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94876946 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.94852470 |
| 97 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94836497 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.93371154 |
| 99 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.93257646 |
| 100 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93109480 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.90662409 |
| 102 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90275693 |
| 103 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89950684 |
| 104 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89209173 |
| 105 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88581183 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87540369 |
| 107 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86319435 |
| 108 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.85701014 |
| 109 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.85438543 |
| 110 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.85286385 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.85071106 |
| 112 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.84833539 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84355340 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83429974 |
| 115 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83229209 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.83187910 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81851503 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80971446 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79363063 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78952573 |
| 121 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78795151 |
| 122 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.75437022 |
| 123 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.75339165 |
| 124 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73319159 |
| 125 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.73095754 |
| 126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72144331 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.70646505 |
| 128 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.68896045 |
| 129 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.65273306 |
| 130 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64952519 |
| 131 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.63954612 |
| 132 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.61516792 |
| 133 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.60712702 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.60482724 |
| 135 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.59357334 |
| 136 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.58789385 |
| 137 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.58789385 |
| 138 | CBP_21632823_ChIP-Seq_H3396_Human | 0.58432468 |
| 139 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.57219920 |
| 140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55999373 |
| 141 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55873868 |
| 142 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.55488477 |
| 143 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.54923409 |
| 144 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.54750278 |
| 145 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.54647930 |
| 146 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.53569822 |
| 147 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.53286875 |
| 148 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52510998 |
| 149 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52412160 |
| 150 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.52050925 |
| 151 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51759748 |
| 152 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.50561467 |
| 153 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50460892 |
| 154 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.50242470 |
| 155 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.49249247 |
| 156 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.48893088 |
| 157 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.48822262 |
| 158 | * RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.48726910 |
| 159 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.47879679 |
| 160 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.47820138 |
| 161 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47329502 |
| 162 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.47070883 |
| 163 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.47026838 |
| 164 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.46445367 |
| 165 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.45539850 |
| 166 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.45157718 |
| 167 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.44952359 |
| 168 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.44718367 |
| 169 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44662841 |
| 170 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44312804 |
| 171 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.44014180 |
| 172 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42945546 |
| 173 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.42740542 |
| 174 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.42688814 |
| 175 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.42619700 |
| 176 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.42611623 |
| 177 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.41693658 |
| 178 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.41447660 |
| 179 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.40295679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.23298031 |
| 2 | MP0005360_urolithiasis | 6.60561403 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.67075940 |
| 4 | MP0005365_abnormal_bile_salt | 5.47379434 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.62009925 |
| 6 | MP0003011_delayed_dark_adaptation | 4.34130696 |
| 7 | MP0009840_abnormal_foam_cell | 4.11350422 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 4.05927491 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.54014864 |
| 10 | MP0009785_altered_susceptibility_to | 3.17208188 |
| 11 | MP0003252_abnormal_bile_duct | 3.02615097 |
| 12 | MP0010155_abnormal_intestine_physiology | 2.98637763 |
| 13 | MP0002132_abnormal_respiratory_system | 2.98153243 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.97607707 |
| 15 | MP0001790_abnormal_immune_system | 2.89837068 |
| 16 | MP0005387_immune_system_phenotype | 2.89837068 |
| 17 | MP0005332_abnormal_amino_acid | 2.79576002 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.70838255 |
| 19 | MP0003436_decreased_susceptibility_to | 2.68599276 |
| 20 | MP0005671_abnormal_response_to | 2.67801525 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.58213717 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.56048002 |
| 23 | MP0005083_abnormal_biliary_tract | 2.53247168 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 2.47802338 |
| 25 | MP0003195_calcinosis | 2.47306235 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 2.37010655 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.36245161 |
| 28 | MP0001666_abnormal_nutrient_absorption | 2.28089392 |
| 29 | MP0001764_abnormal_homeostasis | 2.24160148 |
| 30 | MP0001849_ear_inflammation | 2.12398889 |
| 31 | MP0002006_tumorigenesis | 2.11003168 |
| 32 | MP0001800_abnormal_humoral_immune | 2.08111405 |
| 33 | MP0000685_abnormal_immune_system | 2.06453111 |
| 34 | MP0003724_increased_susceptibility_to | 2.05802835 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 2.05573982 |
| 36 | MP0000609_abnormal_liver_physiology | 1.92932326 |
| 37 | MP0005000_abnormal_immune_tolerance | 1.90727247 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.90598554 |
| 39 | MP0003868_abnormal_feces_composition | 1.87248081 |
| 40 | MP0005025_abnormal_response_to | 1.82284355 |
| 41 | MP0003303_peritoneal_inflammation | 1.78727639 |
| 42 | MP0010352_gastrointestinal_tract_polyps | 1.78683732 |
| 43 | MP0003186_abnormal_redox_activity | 1.73189079 |
| 44 | MP0005319_abnormal_enzyme/_coenzyme | 1.70890778 |
| 45 | MP0002723_abnormal_immune_serum | 1.70601579 |
| 46 | MP0003763_abnormal_thymus_physiology | 1.70058836 |
| 47 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.69628044 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.69421960 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.60514557 |
| 50 | MP0002419_abnormal_innate_immunity | 1.60172809 |
| 51 | MP0002405_respiratory_system_inflammati | 1.58262072 |
| 52 | MP0000490_abnormal_crypts_of | 1.56893597 |
| 53 | MP0006082_CNS_inflammation | 1.54779940 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.54160190 |
| 55 | MP0001819_abnormal_immune_cell | 1.52915268 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.52313567 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.50957208 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.48554094 |
| 59 | MP0004947_skin_inflammation | 1.42903586 |
| 60 | MP0003329_amyloid_beta_deposits | 1.36862742 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.33277359 |
| 62 | MP0005310_abnormal_salivary_gland | 1.30649799 |
| 63 | MP0005253_abnormal_eye_physiology | 1.30269235 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.27246508 |
| 65 | MP0003866_abnormal_defecation | 1.26119588 |
| 66 | MP0000604_amyloidosis | 1.21858953 |
| 67 | MP0001873_stomach_inflammation | 1.21731088 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.20416703 |
| 69 | MP0000716_abnormal_immune_system | 1.18833138 |
| 70 | MP0002398_abnormal_bone_marrow | 1.18765085 |
| 71 | MP0002933_joint_inflammation | 1.18326163 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.15436394 |
| 73 | MP0002090_abnormal_vision | 1.14838808 |
| 74 | MP0005165_increased_susceptibility_to | 1.14034740 |
| 75 | MP0004130_abnormal_muscle_cell | 1.13835107 |
| 76 | MP0003690_abnormal_glial_cell | 1.13304962 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.10744328 |
| 78 | MP0003300_gastrointestinal_ulcer | 1.10578279 |
| 79 | MP0000858_altered_metastatic_potential | 1.09620403 |
| 80 | MP0002722_abnormal_immune_system | 1.08506861 |
| 81 | MP0001853_heart_inflammation | 1.06452298 |
| 82 | MP0003941_abnormal_skin_development | 1.05801943 |
| 83 | MP0006054_spinal_hemorrhage | 1.05713430 |
| 84 | MP0010094_abnormal_chromosome_stability | 1.05563773 |
| 85 | MP0003693_abnormal_embryo_hatching | 1.04721785 |
| 86 | MP0003448_altered_tumor_morphology | 1.03694526 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 1.01356165 |
| 88 | MP0010678_abnormal_skin_adnexa | 0.99687516 |
| 89 | MP0002429_abnormal_blood_cell | 0.99167835 |
| 90 | MP0005376_homeostasis/metabolism_phenot | 0.97891040 |
| 91 | MP0005670_abnormal_white_adipose | 0.97858043 |
| 92 | MP0009697_abnormal_copulation | 0.97689912 |
| 93 | MP0000598_abnormal_liver_morphology | 0.97400896 |
| 94 | MP0002254_reproductive_system_inflammat | 0.96980386 |
| 95 | MP0002138_abnormal_hepatobiliary_system | 0.96243873 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.95737448 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.94442645 |
| 98 | MP0005266_abnormal_metabolism | 0.91547387 |
| 99 | MP0005647_abnormal_sex_gland | 0.89659611 |
| 100 | MP0009764_decreased_sensitivity_to | 0.88774751 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.88652601 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.87747102 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.86273531 |
| 104 | MP0001663_abnormal_digestive_system | 0.85563492 |
| 105 | MP0002876_abnormal_thyroid_physiology | 0.85138923 |
| 106 | MP0009642_abnormal_blood_homeostasis | 0.84346469 |
| 107 | MP0000703_abnormal_thymus_morphology | 0.83329633 |
| 108 | MP0000343_altered_response_to | 0.82400553 |
| 109 | MP0008873_increased_physiological_sensi | 0.81697716 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.81696862 |
| 111 | MP0002971_abnormal_brown_adipose | 0.81640450 |
| 112 | MP0009763_increased_sensitivity_to | 0.81312824 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.81256182 |
| 114 | MP0005451_abnormal_body_composition | 0.81105313 |
| 115 | MP0008872_abnormal_physiological_respon | 0.80237650 |
| 116 | MP0003075_altered_response_to | 0.80197925 |
| 117 | MP0002396_abnormal_hematopoietic_system | 0.79826141 |
| 118 | MP0005334_abnormal_fat_pad | 0.77945340 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.77685398 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.77679534 |
| 121 | MP0005535_abnormal_body_temperature | 0.77556178 |
| 122 | MP0002282_abnormal_trachea_morphology | 0.77396469 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.76961859 |
| 124 | MP0000627_abnormal_mammary_gland | 0.75810829 |
| 125 | MP0005164_abnormal_response_to | 0.75720485 |
| 126 | MP0005397_hematopoietic_system_phenotyp | 0.72653689 |
| 127 | MP0001545_abnormal_hematopoietic_system | 0.72653689 |
| 128 | MP0001986_abnormal_taste_sensitivity | 0.72152227 |
| 129 | MP0005195_abnormal_posterior_eye | 0.71814607 |
| 130 | MP0002229_neurodegeneration | 0.71408316 |
| 131 | MP0000639_abnormal_adrenal_gland | 0.70674649 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.69268746 |
| 133 | MP0001324_abnormal_eye_pigmentation | 0.69185118 |
| 134 | MP0008469_abnormal_protein_level | 0.68863567 |
| 135 | MP0004147_increased_porphyrin_level | 0.68813337 |
| 136 | MP0002822_catalepsy | 0.66708858 |
| 137 | MP0005646_abnormal_pituitary_gland | 0.64242691 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.60839918 |
| 139 | MP0009765_abnormal_xenobiotic_induced | 0.58600944 |
| 140 | MP0004043_abnormal_pH_regulation | 0.56283125 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.55558757 |
| 142 | MP0008874_decreased_physiological_sensi | 0.54219773 |
| 143 | MP0003633_abnormal_nervous_system | 0.53684039 |
| 144 | MP0002837_dystrophic_cardiac_calcinosis | 0.53067031 |
| 145 | MP0009672_abnormal_birth_weight | 0.51859551 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.51382300 |
| 147 | MP0005448_abnormal_energy_balance | 0.50646073 |
| 148 | MP0003953_abnormal_hormone_level | 0.49328058 |
| 149 | MP0005391_vision/eye_phenotype | 0.49206068 |
| 150 | MP0001756_abnormal_urination | 0.48692415 |
| 151 | MP0005464_abnormal_platelet_physiology | 0.45921874 |
| 152 | MP0002332_abnormal_exercise_endurance | 0.44014428 |
| 153 | MP0002970_abnormal_white_adipose | 0.43108784 |
| 154 | MP0001661_extended_life_span | 0.41977068 |
| 155 | MP0003718_maternal_effect | 0.41942134 |
| 156 | MP0003632_abnormal_nervous_system | 0.41848290 |
| 157 | MP0009384_cardiac_valve_regurgitation | 0.41516326 |
| 158 | MP0003631_nervous_system_phenotype | 0.41233307 |
| 159 | MP0005666_abnormal_adipose_tissue | 0.41035151 |
| 160 | MP0005166_decreased_susceptibility_to | 0.39429470 |
| 161 | MP0009780_abnormal_chondrocyte_physiolo | 0.37911404 |
| 162 | MP0005187_abnormal_penis_morphology | 0.37141817 |
| 163 | MP0005084_abnormal_gallbladder_morpholo | 0.36476814 |
| 164 | MP0003890_abnormal_embryonic-extraembry | 0.36138520 |
| 165 | MP0001984_abnormal_olfaction | 0.35271740 |
| 166 | MP0009115_abnormal_fat_cell | 0.33173174 |
| 167 | MP0005395_other_phenotype | 0.31551232 |
| 168 | MP0002638_abnormal_pupillary_reflex | 0.31369102 |
| 169 | MP0004885_abnormal_endolymph | 0.31160465 |
| 170 | MP0004142_abnormal_muscle_tone | 0.30319203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 7.45708075 |
| 2 | Hyperglycinemia (HP:0002154) | 6.99360721 |
| 3 | Absent/shortened dynein arms (HP:0200106) | 6.88613275 |
| 4 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.88613275 |
| 5 | Abnormal respiratory motile cilium morphology (HP:0005938) | 6.70510736 |
| 6 | Abnormal respiratory epithelium morphology (HP:0012253) | 6.70510736 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 6.56748919 |
| 8 | Rhinitis (HP:0012384) | 6.44170157 |
| 9 | Abnormal ciliary motility (HP:0012262) | 6.38983250 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.22644869 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 6.19936712 |
| 12 | Xanthomatosis (HP:0000991) | 6.00622407 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 5.86922254 |
| 14 | Deep venous thrombosis (HP:0002625) | 5.70539708 |
| 15 | Abnormality of glycine metabolism (HP:0010895) | 5.46131000 |
| 16 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.46131000 |
| 17 | Bronchiectasis (HP:0002110) | 5.35167757 |
| 18 | Hyperammonemia (HP:0001987) | 5.33568658 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 5.29856893 |
| 20 | Chronic bronchitis (HP:0004469) | 5.28883326 |
| 21 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.22726298 |
| 22 | Prolonged partial thromboplastin time (HP:0003645) | 4.88411408 |
| 23 | Ketosis (HP:0001946) | 4.87686319 |
| 24 | Nasal polyposis (HP:0100582) | 4.69913856 |
| 25 | Hypolipoproteinemia (HP:0010981) | 4.56983037 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.47799457 |
| 27 | Dyschromatopsia (HP:0007641) | 4.22616698 |
| 28 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14427182 |
| 29 | Hypoglycemic coma (HP:0001325) | 4.08670153 |
| 30 | Hyperglycinuria (HP:0003108) | 4.08362313 |
| 31 | Complement deficiency (HP:0004431) | 4.05006419 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 4.01945749 |
| 33 | Tetraparesis (HP:0002273) | 3.93652365 |
| 34 | Bronchitis (HP:0012387) | 3.85543604 |
| 35 | Abnormality of serum amino acid levels (HP:0003112) | 3.85097068 |
| 36 | Epidermoid cyst (HP:0200040) | 3.67574790 |
| 37 | Pigmentary retinal degeneration (HP:0001146) | 3.59499229 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.48430190 |
| 39 | Chronic sinusitis (HP:0011109) | 3.48143788 |
| 40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.42625507 |
| 41 | Dicarboxylic aciduria (HP:0003215) | 3.42342860 |
| 42 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.42342860 |
| 43 | Methylmalonic acidemia (HP:0002912) | 3.41477866 |
| 44 | Recurrent sinusitis (HP:0011108) | 3.37682602 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36442484 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.35017701 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 3.28042270 |
| 48 | Joint hemorrhage (HP:0005261) | 3.27981780 |
| 49 | Delayed CNS myelination (HP:0002188) | 3.24923381 |
| 50 | Hyperactive renin-angiotensin system (HP:0000841) | 3.21696875 |
| 51 | Congenital stationary night blindness (HP:0007642) | 3.21049833 |
| 52 | Abnormality of B cell number (HP:0010975) | 3.18216789 |
| 53 | B lymphocytopenia (HP:0010976) | 3.16738110 |
| 54 | Methylmalonic aciduria (HP:0012120) | 3.16499724 |
| 55 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.14495113 |
| 56 | Fat malabsorption (HP:0002630) | 3.13217792 |
| 57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.13140085 |
| 58 | Ketoacidosis (HP:0001993) | 3.09369119 |
| 59 | Recurrent otitis media (HP:0000403) | 3.06747880 |
| 60 | Hypercholesterolemia (HP:0003124) | 3.04556712 |
| 61 | Metabolic acidosis (HP:0001942) | 3.03556417 |
| 62 | Hyperbilirubinemia (HP:0002904) | 2.92065442 |
| 63 | Recurrent bronchitis (HP:0002837) | 2.86997545 |
| 64 | Lethargy (HP:0001254) | 2.82012229 |
| 65 | Abnormality of complement system (HP:0005339) | 2.80217940 |
| 66 | Chorioretinal atrophy (HP:0000533) | 2.74030868 |
| 67 | Male infertility (HP:0003251) | 2.69232448 |
| 68 | Posterior subcapsular cataract (HP:0007787) | 2.68192466 |
| 69 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.66090554 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.65955131 |
| 71 | Chronic otitis media (HP:0000389) | 2.60760442 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.59807566 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.56050789 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.55935156 |
| 75 | Gout (HP:0001997) | 2.53834502 |
| 76 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.51963835 |
| 77 | Spontaneous abortion (HP:0005268) | 2.50315508 |
| 78 | Generalized aminoaciduria (HP:0002909) | 2.49987915 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.49509993 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.48886621 |
| 81 | Tubulointerstitial fibrosis (HP:0005576) | 2.46687012 |
| 82 | Infertility (HP:0000789) | 2.45364322 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38846812 |
| 84 | Upper motor neuron abnormality (HP:0002127) | 2.38669070 |
| 85 | Steatorrhea (HP:0002570) | 2.36665044 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.35944515 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.33095202 |
| 88 | Abnormality of macular pigmentation (HP:0008002) | 2.32409773 |
| 89 | Panhypogammaglobulinemia (HP:0003139) | 2.31700473 |
| 90 | Acanthocytosis (HP:0001927) | 2.31412402 |
| 91 | Vomiting (HP:0002013) | 2.31407166 |
| 92 | Skin nodule (HP:0200036) | 2.29034736 |
| 93 | Hypoplasia of the uterus (HP:0000013) | 2.27972407 |
| 94 | Tetraplegia (HP:0002445) | 2.27015127 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.25292652 |
| 96 | Hypoplasia of the thymus (HP:0000778) | 2.23002660 |
| 97 | Central scotoma (HP:0000603) | 2.22511751 |
| 98 | Periodontitis (HP:0000704) | 2.22251089 |
| 99 | Thyroiditis (HP:0100646) | 2.21993823 |
| 100 | Abnormality of T cell number (HP:0011839) | 2.21760167 |
| 101 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.21713931 |
| 102 | Premature loss of primary teeth (HP:0006323) | 2.20003376 |
| 103 | Glucose intolerance (HP:0000833) | 2.18619574 |
| 104 | Vitreoretinal degeneration (HP:0000655) | 2.18310412 |
| 105 | Recurrent cutaneous fungal infections (HP:0011370) | 2.17447256 |
| 106 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.17447256 |
| 107 | T lymphocytopenia (HP:0005403) | 2.17232520 |
| 108 | Recurrent abscess formation (HP:0002722) | 2.16840782 |
| 109 | Late onset (HP:0003584) | 2.16787258 |
| 110 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.14906779 |
| 111 | Recurrent bacterial skin infections (HP:0005406) | 2.12060396 |
| 112 | Renal cortical cysts (HP:0000803) | 2.10942437 |
| 113 | Spastic diplegia (HP:0001264) | 2.09798819 |
| 114 | Severe combined immunodeficiency (HP:0004430) | 2.08948215 |
| 115 | Cerebral edema (HP:0002181) | 2.08622706 |
| 116 | Abnormal gallbladder morphology (HP:0012437) | 2.07377232 |
| 117 | Respiratory distress (HP:0002098) | 2.07196267 |
| 118 | Neonatal onset (HP:0003623) | 2.07101684 |
| 119 | Irritability (HP:0000737) | 2.07015736 |
| 120 | Myocardial infarction (HP:0001658) | 2.05929766 |
| 121 | Decreased central vision (HP:0007663) | 2.05050486 |
| 122 | Scotoma (HP:0000575) | 2.02138053 |
| 123 | Delayed myelination (HP:0012448) | 2.02062927 |
| 124 | Recurrent fungal infections (HP:0002841) | 2.01573001 |
| 125 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.01494247 |
| 126 | Cholelithiasis (HP:0001081) | 2.01426170 |
| 127 | IgM deficiency (HP:0002850) | 2.00910673 |
| 128 | Hypoproteinemia (HP:0003075) | 1.99801056 |
| 129 | Pendular nystagmus (HP:0012043) | 1.98744297 |
| 130 | Hypoglycemic seizures (HP:0002173) | 1.98374746 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.97324642 |
| 132 | Decreased circulating renin level (HP:0003351) | 1.96394413 |
| 133 | Hepatocellular carcinoma (HP:0001402) | 1.96177165 |
| 134 | Spastic paraparesis (HP:0002313) | 1.95931925 |
| 135 | Abolished electroretinogram (ERG) (HP:0000550) | 1.94428133 |
| 136 | Dysostosis multiplex (HP:0000943) | 1.94317458 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.94035301 |
| 138 | Abnormality of vitamin B metabolism (HP:0004340) | 1.91800776 |
| 139 | Vascular calcification (HP:0004934) | 1.91743637 |
| 140 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.91048776 |
| 141 | Macular degeneration (HP:0000608) | 1.90644263 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.90374775 |
| 143 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.90320078 |
| 144 | Flat acetabular roof (HP:0003180) | 1.90168768 |
| 145 | Cholecystitis (HP:0001082) | 1.88862310 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.88862310 |
| 147 | Status epilepticus (HP:0002133) | 1.85979901 |
| 148 | Recurrent pneumonia (HP:0006532) | 1.85921206 |
| 149 | Combined immunodeficiency (HP:0005387) | 1.85892389 |
| 150 | Abnormality of T cells (HP:0002843) | 1.85285788 |
| 151 | Stomatitis (HP:0010280) | 1.85127534 |
| 152 | Recurrent viral infections (HP:0004429) | 1.84994548 |
| 153 | Abnormality of chloride homeostasis (HP:0011422) | 1.84816365 |
| 154 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83462376 |
| 155 | Renal salt wasting (HP:0000127) | 1.82802160 |
| 156 | Myositis (HP:0100614) | 1.82281038 |
| 157 | Abnormal spermatogenesis (HP:0008669) | 1.79972282 |
| 158 | Neurodegeneration (HP:0002180) | 1.79935542 |
| 159 | Loss of speech (HP:0002371) | 1.78872600 |
| 160 | Mitral stenosis (HP:0001718) | 1.77938454 |
| 161 | Tubulointerstitial abnormality (HP:0001969) | 1.77885873 |
| 162 | Mucopolysacchariduria (HP:0008155) | 1.77234653 |
| 163 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77234653 |
| 164 | Orchitis (HP:0100796) | 1.77095451 |
| 165 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.76412734 |
| 166 | Abnormality of iron homeostasis (HP:0011031) | 1.76343526 |
| 167 | Median cleft lip (HP:0000161) | 1.75536476 |
| 168 | Hyperventilation (HP:0002883) | 1.73684233 |
| 169 | Malnutrition (HP:0004395) | 1.72870782 |
| 170 | Proximal tubulopathy (HP:0000114) | 1.69202952 |
| 171 | Increased cerebral lipofuscin (HP:0011813) | 1.67967743 |
| 172 | Abnormality of macrophages (HP:0004311) | 1.67045788 |
| 173 | Recurrent skin infections (HP:0001581) | 1.66504221 |
| 174 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.66158201 |
| 175 | Eosinophilia (HP:0001880) | 1.66096995 |
| 176 | Hypokinesia (HP:0002375) | 1.65819246 |
| 177 | Chronic diarrhea (HP:0002028) | 1.64704709 |
| 178 | Subcapsular cataract (HP:0000523) | 1.63082987 |
| 179 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.59496264 |
| 180 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.58782418 |
| 181 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.58782418 |
| 182 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.58782418 |
| 183 | Meningitis (HP:0001287) | 1.57638987 |
| 184 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.57621461 |
| 185 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.57621461 |
| 186 | Abnormality of glycolipid metabolism (HP:0010969) | 1.57621461 |
| 187 | Azoospermia (HP:0000027) | 1.56863024 |
| 188 | Retrobulbar optic neuritis (HP:0100654) | 1.56853397 |
| 189 | Optic neuritis (HP:0100653) | 1.56853397 |
| 190 | Tubulointerstitial nephritis (HP:0001970) | 1.56117130 |
| 191 | Abnormality of the frontal sinuses (HP:0002687) | 1.54520906 |
| 192 | Mucosal telangiectasiae (HP:0100579) | 1.54270433 |
| 193 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.54258503 |
| 194 | Abnormality of renin-angiotensin system (HP:0000847) | 1.53741755 |
| 195 | Hyperaldosteronism (HP:0000859) | 1.52291830 |
| 196 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.51698895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.87692041 |
| 2 | MST4 | 5.70379878 |
| 3 | CAMK1D | 5.40331569 |
| 4 | EIF2AK3 | 4.55360367 |
| 5 | CAMK1G | 3.78554079 |
| 6 | PINK1 | 3.42858134 |
| 7 | SIK1 | 3.39772767 |
| 8 | CAMKK2 | 3.08848959 |
| 9 | RIPK4 | 2.96649640 |
| 10 | EPHA2 | 2.94685020 |
| 11 | ACVR1B | 2.81821263 |
| 12 | TLK1 | 2.73990855 |
| 13 | GRK1 | 2.55879112 |
| 14 | FGFR4 | 2.54683991 |
| 15 | MAP2K4 | 2.50438457 |
| 16 | FLT3 | 2.27287010 |
| 17 | MAPKAPK3 | 2.25884134 |
| 18 | MAPK15 | 2.20600508 |
| 19 | ERN1 | 2.13648592 |
| 20 | MAP3K3 | 2.08126220 |
| 21 | TRIB3 | 2.07759013 |
| 22 | CAMKK1 | 2.07499194 |
| 23 | MAP3K12 | 1.96946575 |
| 24 | TYK2 | 1.85428850 |
| 25 | MAP3K14 | 1.73183790 |
| 26 | PIK3CA | 1.71376497 |
| 27 | TBK1 | 1.66969719 |
| 28 | TESK2 | 1.56454625 |
| 29 | SCYL2 | 1.55893301 |
| 30 | FRK | 1.54003114 |
| 31 | SMG1 | 1.50819936 |
| 32 | BMPR2 | 1.49496479 |
| 33 | EPHA4 | 1.46308385 |
| 34 | MAPK11 | 1.44785110 |
| 35 | ERBB4 | 1.39289255 |
| 36 | MAP3K2 | 1.32352207 |
| 37 | TTK | 1.30303301 |
| 38 | STK10 | 1.30041358 |
| 39 | TIE1 | 1.29468754 |
| 40 | BLK | 1.28746779 |
| 41 | STK24 | 1.27974096 |
| 42 | TAOK3 | 1.27654390 |
| 43 | INSRR | 1.23669943 |
| 44 | TXK | 1.21586693 |
| 45 | NEK9 | 1.19682940 |
| 46 | PHKG1 | 1.15354987 |
| 47 | PHKG2 | 1.15354987 |
| 48 | MAPK12 | 1.11666388 |
| 49 | CSK | 1.11537577 |
| 50 | STK39 | 1.10661696 |
| 51 | NEK6 | 1.10188175 |
| 52 | ZAK | 1.06135399 |
| 53 | NEK1 | 1.02105257 |
| 54 | MINK1 | 1.01393284 |
| 55 | EIF2AK1 | 1.00908347 |
| 56 | MAP4K1 | 0.99599464 |
| 57 | CAMK1 | 0.99475388 |
| 58 | IKBKE | 0.99058528 |
| 59 | LMTK2 | 0.97995843 |
| 60 | BTK | 0.96151766 |
| 61 | OXSR1 | 0.94478303 |
| 62 | CLK1 | 0.94410849 |
| 63 | ZAP70 | 0.93993506 |
| 64 | PASK | 0.91188207 |
| 65 | NUAK1 | 0.90195327 |
| 66 | PDK1 | 0.88605353 |
| 67 | PRKCH | 0.88337215 |
| 68 | CSF1R | 0.88127001 |
| 69 | PRKCI | 0.87852130 |
| 70 | RPS6KB2 | 0.87427780 |
| 71 | PRKACG | 0.87098572 |
| 72 | BRSK2 | 0.86556318 |
| 73 | IKBKB | 0.85815917 |
| 74 | TGFBR2 | 0.85589732 |
| 75 | DAPK2 | 0.83788816 |
| 76 | MAP3K11 | 0.83640255 |
| 77 | ABL2 | 0.82671162 |
| 78 | IRAK3 | 0.81125474 |
| 79 | PIM2 | 0.77052384 |
| 80 | PAK4 | 0.75209805 |
| 81 | PKN2 | 0.75187334 |
| 82 | PIK3CG | 0.73662907 |
| 83 | SGK2 | 0.73485741 |
| 84 | PRKAA2 | 0.73412794 |
| 85 | NTRK1 | 0.73214846 |
| 86 | CDK19 | 0.73143575 |
| 87 | PRKCG | 0.71762172 |
| 88 | CHUK | 0.71677798 |
| 89 | JAK3 | 0.71542396 |
| 90 | JAK1 | 0.71266792 |
| 91 | CAMK4 | 0.70837323 |
| 92 | MAPK4 | 0.70554151 |
| 93 | TRIM28 | 0.69571469 |
| 94 | PBK | 0.69497604 |
| 95 | BMPR1B | 0.69383325 |
| 96 | SRPK1 | 0.68714363 |
| 97 | CDK6 | 0.68544098 |
| 98 | LATS2 | 0.67934289 |
| 99 | LYN | 0.67784618 |
| 100 | RIPK1 | 0.67664130 |
| 101 | NME2 | 0.67072383 |
| 102 | EPHB1 | 0.64709761 |
| 103 | STK16 | 0.64059792 |
| 104 | IRAK4 | 0.62210382 |
| 105 | EPHA3 | 0.61753129 |
| 106 | YES1 | 0.61618355 |
| 107 | NTRK3 | 0.61241690 |
| 108 | MAP2K7 | 0.61153515 |
| 109 | PDPK1 | 0.59923419 |
| 110 | IRAK2 | 0.59557845 |
| 111 | ADRBK1 | 0.58397219 |
| 112 | FER | 0.58007843 |
| 113 | RAF1 | 0.57882926 |
| 114 | LCK | 0.57832075 |
| 115 | MAP2K1 | 0.57586119 |
| 116 | PRKAA1 | 0.55372954 |
| 117 | KDR | 0.55275680 |
| 118 | SGK494 | 0.54961054 |
| 119 | SGK223 | 0.54961054 |
| 120 | SIK3 | 0.54473644 |
| 121 | SYK | 0.53777171 |
| 122 | TSSK6 | 0.53454149 |
| 123 | MAP3K13 | 0.53276161 |
| 124 | PLK3 | 0.52740509 |
| 125 | ILK | 0.52621363 |
| 126 | CDK7 | 0.52259657 |
| 127 | CAMK2G | 0.52249510 |
| 128 | SGK3 | 0.50552130 |
| 129 | PDK3 | 0.49985291 |
| 130 | PDK4 | 0.49985291 |
| 131 | VRK2 | 0.49932407 |
| 132 | LRRK2 | 0.47260927 |
| 133 | RPS6KB1 | 0.47198309 |
| 134 | MET | 0.46884169 |
| 135 | MAP3K7 | 0.45115132 |
| 136 | MAPK7 | 0.45078760 |
| 137 | TNK2 | 0.44982531 |
| 138 | CDK5 | 0.43751013 |
| 139 | MAP3K8 | 0.43746706 |
| 140 | FGFR3 | 0.43060853 |
| 141 | JAK2 | 0.42935073 |
| 142 | TESK1 | 0.42726521 |
| 143 | DAPK1 | 0.42692534 |
| 144 | BCR | 0.42276924 |
| 145 | TRPM7 | 0.41980994 |
| 146 | PAK3 | 0.41926100 |
| 147 | GRK5 | 0.41805240 |
| 148 | EEF2K | 0.40533890 |
| 149 | PRKCZ | 0.40492529 |
| 150 | HCK | 0.40142829 |
| 151 | CSNK1A1 | 0.39655460 |
| 152 | MAP2K3 | 0.38058626 |
| 153 | PAK1 | 0.36706393 |
| 154 | ERBB2 | 0.36600753 |
| 155 | GRK6 | 0.34399654 |
| 156 | PRKACB | 0.33995686 |
| 157 | PRKD1 | 0.33363738 |
| 158 | MST1R | 0.32932669 |
| 159 | LATS1 | 0.32887011 |
| 160 | PRKCA | 0.32696817 |
| 161 | KIT | 0.32067427 |
| 162 | EIF2AK2 | 0.31556092 |
| 163 | PRKCD | 0.31197942 |
| 164 | STK38 | 0.31159879 |
| 165 | TAOK2 | 0.31054314 |
| 166 | ARAF | 0.30776069 |
| 167 | ERBB3 | 0.30605355 |
| 168 | TAF1 | 0.30571061 |
| 169 | PRKACA | 0.28823275 |
| 170 | MATK | 0.28623907 |
| 171 | MAP3K1 | 0.28587755 |
| 172 | MYLK | 0.28270438 |
| 173 | IGF1R | 0.27550809 |
| 174 | PRKCB | 0.26108845 |
| 175 | RPS6KA3 | 0.25877611 |
| 176 | GRK7 | 0.25642924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.58385087 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.08533971 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.09848127 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.08584993 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.91643143 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89468608 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.88421127 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.87145771 |
| 9 | Phototransduction_Homo sapiens_hsa04744 | 2.78619044 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.62195385 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.58168035 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.41512437 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.38152237 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37796781 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.34808671 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.25326479 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11929237 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09730625 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.07145895 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.07099699 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.04255620 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 2.00525807 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98618294 |
| 24 | * Caffeine metabolism_Homo sapiens_hsa00232 | 1.92774106 |
| 25 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.89278261 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83353577 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.82662439 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.81590532 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81347018 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.79125742 |
| 31 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76904140 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76172122 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76090382 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.75143028 |
| 35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72821897 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.69178771 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67715855 |
| 38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65921020 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65408790 |
| 40 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.63276008 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57023166 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.55403761 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53997452 |
| 44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52836567 |
| 45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.52557534 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52503971 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.51581585 |
| 48 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51099363 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.49747851 |
| 50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49701346 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49342147 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.44810082 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.43981882 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.43106711 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40886012 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39773080 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37633457 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 1.33942553 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33196184 |
| 60 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32183751 |
| 61 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31605291 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28876442 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28130874 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23369198 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22763279 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 1.22425956 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.19899536 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 1.19604503 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18856835 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16931826 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16289770 |
| 72 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.12660837 |
| 73 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12185427 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12000116 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09817086 |
| 76 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09620975 |
| 77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06514631 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.04674965 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.04341274 |
| 80 | ABC transporters_Homo sapiens_hsa02010 | 1.02052695 |
| 81 | Tuberculosis_Homo sapiens_hsa05152 | 1.01557116 |
| 82 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99515503 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.97590857 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.97263440 |
| 85 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97238217 |
| 86 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96762297 |
| 87 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.95068059 |
| 88 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94903057 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93865198 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92093338 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91194079 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90536407 |
| 93 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.90164563 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.90135568 |
| 95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88189569 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87905340 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.86530513 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85908945 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85350210 |
| 100 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84171877 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.82206141 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81637104 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73204072 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70693724 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.70130654 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.67811273 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67041843 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66313630 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.66020802 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.64341451 |
| 111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62690616 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62028623 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.61666259 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61227147 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58332246 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | 0.56119561 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56018748 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.54398285 |
| 119 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52225886 |
| 120 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50065748 |
| 121 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49825489 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49060361 |
| 123 | Lysine degradation_Homo sapiens_hsa00310 | 0.48283103 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47785507 |
| 125 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45349195 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40844627 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.40687281 |
| 128 | Phagosome_Homo sapiens_hsa04145 | 0.39419636 |
| 129 | Hepatitis B_Homo sapiens_hsa05161 | 0.39115359 |
| 130 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37878681 |
| 131 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37293170 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37291344 |
| 133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.34198514 |
| 134 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.32774344 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30652787 |
| 136 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27527313 |
| 137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25996462 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.25019859 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.20369111 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14042028 |
| 141 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10424211 |
| 142 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08807314 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06586902 |
| 144 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.04568717 |
| 145 | GABAergic synapse_Homo sapiens_hsa04727 | 0.02714407 |
| 146 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.02321470 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1711664 |
| 148 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.1604389 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1527128 |
| 150 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1387572 |
| 151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1235315 |
| 152 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1027332 |
| 153 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0980405 |
| 154 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0973448 |
| 155 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0902244 |
| 156 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0733272 |
| 157 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0581350 |
| 158 | Purine metabolism_Homo sapiens_hsa00230 | -0.0576693 |
| 159 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0505194 |
| 160 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0385000 |
| 161 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0295243 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0113083 |

